1148 related articles for article (PubMed ID: 28146134)
1. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
Kamps R; Brandão RD; Bosch BJ; Paulussen AD; Xanthoulea S; Blok MJ; Romano A
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146134
[TBL] [Abstract][Full Text] [Related]
2. Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J; Zemankova P; Lhotova K; Janatova M; Borecka M; Stolarova L; Lhota F; Foretova L; Machackova E; Stranecky V; Tavandzis S; Kleiblova P; Vocka M; Hartmannova H; Hodanova K; Kmoch S; Kleibl Z
PLoS One; 2018; 13(4):e0195761. PubMed ID: 29649263
[TBL] [Abstract][Full Text] [Related]
3. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
5. Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines.
Marcus RK; Geurts JL; Grzybowski JA; Turaga KK; Clark Gamblin T; Strong KA; Johnston FM
Fam Cancer; 2015 Dec; 14(4):641-9. PubMed ID: 26108897
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
7. Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.
Paulo P; Pinto P; Peixoto A; Santos C; Pinto C; Rocha P; Veiga I; Soares G; Machado C; Ramos F; Teixeira MR
J Mol Diagn; 2017 Jul; 19(4):502-513. PubMed ID: 28529006
[TBL] [Abstract][Full Text] [Related]
8. Whole Exome Sequencing: The Next Phase of Genetics Care.
Mahon SM
Oncol Nurs Forum; 2016 Mar; 43(2):249-52. PubMed ID: 26906136
[TBL] [Abstract][Full Text] [Related]
9. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
10. Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.
Shimoda Y; Nagashima T; Urakami K; Tanabe T; Saito J; Naruoka A; Serizawa M; Mochizuki T; Ohshima K; Ohnami S; Ohnami S; Kusuhara M; Yamaguchi K
Biomed Res; 2016; 37(6):367-379. PubMed ID: 28003584
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiling in oncology clinical practice.
Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of amplicon-based next-generation sequencing in cancer.
Chang F; Li MM
Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
[TBL] [Abstract][Full Text] [Related]
13. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
15. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.
Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W
Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974
[TBL] [Abstract][Full Text] [Related]
16. Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.
Smith A; Boycott KM; Jarinova O
Hum Mutat; 2014 Feb; 35(2):265-9. PubMed ID: 24282140
[TBL] [Abstract][Full Text] [Related]
17. [Genome sequencing and personalized medicine: perspectives and limitations].
Le Gall JY; Debré P;
Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
[TBL] [Abstract][Full Text] [Related]
18. The clinical utility of molecular genetic cancer profiling.
Joseph L
Expert Rev Mol Diagn; 2016 Aug; 16(8):827-38. PubMed ID: 27253039
[TBL] [Abstract][Full Text] [Related]
19. Consensus document on the implementation of next generation sequencing in the genetic diagnosis of hereditary cancer.
Soto JL; Blanco I; Díez O; García Planells J; Lorda I; Matthijs G; Robledo M; Souche E; Lázaro C
Med Clin (Barc); 2018 Jul; 151(2):80.e1-80.e10. PubMed ID: 29439875
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Value of Next-Generation Sequencing Tests in a Dynamic Environment.
Burris HA; Saltz LB; Yu PP
Am Soc Clin Oncol Educ Book; 2018 May; 38():139-146. PubMed ID: 30231307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]